Well-known sensitivity and specificity limitations [7, 8] of prostate-specific antigen (PSA) testing for PCa detection, monitoring and prognosis [3], have prompted research into liquid biopsy assays as a source of PCa-specific biomarkers. The gene discussed is KLK3; the disease is posterior cortical atrophy.